Mark Adams
Table of Contents show
About Be Biopharma
Be Biopharma is developing B cells as medicines.
Website: Learn more on Be Biopharma’s website
Crunchbase: Follow on Crunchbase
[adace-ad id=”4426″]Series A – Be Biopharma
| Amount Raised | 52000000 USD |
| Announced Date | 2020-10-22 |
| Equity Only Funding | Yes |
| Organization Location | Cambridge, Massachusetts, United States, North America |
| Funding Status | Early Stage Venture |
| Number of Funding Rounds | 1 |
| Lead Investors | Atlas Venture, RA Capital Management |
| Number of Investors | 5 |
| Number of Partner Investors | 2 |
